04/10/2020 10:58 AM EDT |
 |
| Neuro-oncologist Mark Gilbert, M.D., shares information about a clinical trial at NIH investigating the effectiveness of a drug to treat people with recurrent ependymoma. He explains the goal of the trial, who can participate and how, and what a patient can expect. Trial ID 19-C-0011. Learn more at www.cancer.gov/clinicaltrials/ |
lunes, 13 de abril de 2020
Clinical Trial to Treat Ependymoma
Suscribirse a:
Enviar comentarios (Atom)
No hay comentarios:
Publicar un comentario